Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 3 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The Boots Company PLC maintains a portfolio with 11 pending office actions, all situated within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 11 distinct examiners, indicating a spread of individual oversight for the company's intellectual property. Despite the high number of examiners, the work is contained within 3 distinct art units, suggesting that while many individuals are involved, the subject matter remains focused on specific technical classifications.
BECKHARDT, LYNDSEY MARIE is identified as the busiest examiner for the portfolio, though she is responsible for only 1 pending office action. This parity between the busiest examiner's load and the total count of 11 distinct examiners shows that no single official is currently managing a disproportionate share of the pending workload. Practitioners should prepare for a diverse range of examiner perspectives within a limited set of art units. The requirement to manage 11 distinct examiners across just 3 art units implies that multiple examiners are working within the same technical groups, which may lead to varying interpretations of similar subject matter.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (45%) |
| §103 only | 2 (18%) |
| §112 only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 2 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| PRAGANI, RAJAN | 1 | 53.3% | +70.0% |
| PIPIC, ALMA | 1 | 54.6% | +54.7% |
| BARHAM, BETHANY P | 1 | 51.7% | +32.1% |
| AFREMOVA, VERA | 1 | 50.5% | +29.1% |
| MI, QIUWEN | 1 | 68.4% | +49.9% |
| SAEED, ALI S | 1 | 31.3% | +35.8% |
| BANERJEE, KOYELI | 1 | 50.0% | +0.0% |
| LIEB, JEANETTE M | 1 | 79.9% | +17.2% |
| BOWLES, DAVID PAUL | 1 | 72.7% | +22.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | — |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | — |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | — |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | — |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | — |
| 18686955 | COSMETIC COMPOSITIONS | BANERJEE, KOYELI | — |
| 18687112 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | LIEB, JEANETTE M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037447 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | BOWLES, DAVID PAUL | 73d overdue |
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | — |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | — |
| 18839529 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | PIPIC, ALMA | — |
| 18839069 | Antioxidant Compositions | BARHAM, BETHANY P | — |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | — |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | — |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1611 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | — | §102§103 | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | — | §101§103§112DP | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18839529 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | PIPIC, ALMA | — | §103 | Final Rejection | — | Pending | Aug 19, 2024 |
| 18839069 | Antioxidant Compositions | BARHAM, BETHANY P | 1611 | §103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | — | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | — | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | 1615 | §101§103§112DP | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18686955 | COSMETIC COMPOSITIONS | BANERJEE, KOYELI | — | §101§103§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18687112 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | LIEB, JEANETTE M | — | §102§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18037447 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | BOWLES, DAVID PAUL | 1654 | §112Other | Final Rejection | 73d overdue | Pending | May 17, 2023 |
| 18037463 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | HA, JULIE | 1654 | §112DP | Final Rejection | 4d overdue | Pending | May 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial